Influence of different heparin concentrations on the results of in vitro investigations in plasmaseparation technology using capillary membrane filters

Artificial Organs

Volumn 27, Issue 7, 2003, Pages 649-657

  Unger, Juliane Katharina ^a   Haltern, Claudia ^a   Dohmen, Bernd ^a   Rossaint, Rolf ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Anticoagulation; Clearance; Heparin; In vitro; Plasmapheresis; Porcine blood

Indexed keywords

CLINICAL RESEARCH; DETOXIFICATION; MICROFILTRATION; PLASMA (HUMAN); PLATELETS; POLYSACCHARIDES;

ANTI-COAGULATION; CAPILLARY MEMBRANES; CLEARANCE; HAEMOCOMPATIBILITY; HEPARINIZATION; IN-VITRO; MEMBRANE FILTERS; PLASMAPHERESIS; PORCINE BLOODS; VITRO SYSTEM;

COAGULATION;

HEPARIN;

ARTICLE; BLOOD; BLOOD CLOTTING; CAPILLARY WALL; FLOW KINETICS; FLOW RATE; HEMOLYSIS; HEMOPERFUSION; HEPARINIZATION; IN VITRO STUDY; MEDICAL TECHNOLOGY; MEMBRANE FILTER; NONHUMAN; PLASMAPHERESIS; PRESSURE; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ANIMALIA; SUIDAE;

EID: 0037560252     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2003.07132.x     Document Type: Article

References (25)

1. Unger JK, Janssen VR, Kashefi A, Haltern C, Klosterhalfen B, Fischer Y, Gressner AM, Rossaint R. Enhancing filtration rates by the use of blood flow around the capillaries of plasmafilters - an in vitro study. Int J Artif Organs 2001;24:821-31.
2. Unger JK, Janssen V, Kashefi A, Horn NA, Blumberg A, Rossaint R. Concepts to increase plasmafiltration rates for an improved clearance of liver support systems (LSS). Int J Artif Organs 2000;23:515.
3. Unger JK, Horn NA, Kashefi A, Blumberg A, Klosterhalfen B, Rossaint R. The influence of hypoalbuminemia on maximal flow rates and transmembrane pressure during plasmapheresis - an in vitro study. Blood Purif 2001;19:408-16.
4. Unger JK, Haltern C, Siepen W, Rossaint R. The balance of TMP and Pa-Pv in plasma- and hemofilters. Int J Artif Organs 2001;24:561.
5. Mueller XM, Tevaearai HT, Jegger D, Tucker O, Von Segesser LK. Hemolysis and hematology profile during perfusion: interspecies comparison. Int J Artif Organs 2001;24:89-94.
6. Mueller XM, Tevaearai HT, Jegger D, Tucker O, von Segesser LK. Are standard human coagulation tests suitable in pigs and calves during extracorporeal circulation? Artif Organs 2001;25:579-84.
7. Janssen MJ, van der Meulen J. The bleeding risk in chronic haemodialysis: preventive strategies in high-risk patients. Neth J Med 1996;48:198-207.
8. Abramson S, Niles JL. Anticoagulation in continuous renal replacement therapy. Curr Opin Nephrol Hypertens 1999;8:701-7.
9. Apsner R, Buchmayer H, Lang T, Unver B, Speiser W, Sunder-Plassmann G, Horl WH. Simplified citrate anticoagulation for high-flux hemodialysis. Am J Kidney Dis 2001;38:979-87.
10. Hofbauer R, Moser D, Frass M, Oberbauer R, Kaye AD, Wagner O, Kapiotis S, Druml W. Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int 1999;56:1578-83.
11. Tolwani AJ, Campell RC, Schenk MB, Allon M, Warnock DG. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001;60:370-4.
12. Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999;55:191-7.
13. Bosch T, Heinemann O, Duhr C, Wendler T, Keller C, Fink E, Kirschner T, Klebert S, Samtleben W. Effect of low-dose citrate anticoagulation on the clinical safety and efficacy of direct adsorption of lipoproteins (DALI apheresis) in hypercholesterolemic patients: a prospective controlled clinical trail. Artif Organs 2000;24:790-6.
14. Thomas HP, Kassner U, Schliesser C, Steinhagen-Thiessen E. DALI LDL-apheresis: anticoagulation with r-hirudin in a patient with heparin-induced thrombocytopenia (HIT II). Int J Artif Organs 2000;23:637-41.
15. Omokawa S, Malchesky PS, Yamashita M, Goldcamp JB, Nosé Y. Anticoagulation and membrane effects on humoral and cellular changes during plasmapheresis. ASAIO Trans 1988;34:404-9.
16. Reimann PM, Mason PD. Plasmapheresis: technique and complications. Intensive Care Med 1990;16:3-10.
17. Gerlach JC, Botsch M, Kardassis D, Lemmens P, Schön M, Janke J, Puhl G, Unger J, Kraemer M, Busse B, Böhmer C, Belal R, Ingenlath M, Kosan M, Kosan B, Sültmann J, Patzold A, Tietze S, Rossaint R, Müller C, Mönch E, Sauer IM, Neuhaus P. Experimental evaluation of a cell module for hybrid liver support. Int J Artif Organs 2001;24:793-8.
18. Sueoka A. Present status of apheresis technologies: Part 1. Membrane plasma separator. Ther Apher 1997;1:42-6.
19. Lacombe C, Bucherer C, Ladjouzi J, Lelievre JC. Competitive role between fibrinogen and albumin on thixotropy of red cell suspensions. Biorheology 1988;25:349-54.
20. Maeda N, Shiga T. Opposite effect of albumin on the erythrocyte aggregation induced by immunoglobulin G and fibrinogen. Biochim Biophys Acta 1986;855:127-35.
21. Fadul JE, Linde T, Sandhagen B, Wikstrom B, Danielson BG. Effects of extracorporeal hemapheresis therapy on blood rheology. J Clin Apheresis 1997;12:183-6.
22. Rogausch H. The apparent viscosity of aggregating and non-aggregating erythrocyte suspensions in the isolated perfused liver. Biorheology 1987;24:163-71.
23. Trobisch H. Alterations of the hemostaseologic system under extracorporeal conditions. In: Baykut D, Krian A, eds. Current perspectives of the extracorporeal circulation. New York: Springer, 2000:47-51.
24. Haltern C, Unger JK, Dohmen B, Gressner AM, Rossaint R. The influence of HES on the filtration properties of capillary membrane plasmaseparation. Int J Artif Organs 2002;25:798-805.
25. Siepen W, Unger JK, Haltern C, Tayhan F, Dohmen B, Rossaint R. Influence of different volume substitutes on the performance of haemofilters - an in vitro study. Int J Artif Organs 2001;24:563.